Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5602482 | Heart, Lung and Circulation | 2017 | 9 Pages |
Abstract
Atrial fibrillation (AF) and obstructive sleep apnoea (OSA) are both common, often underdiagnosed conditions with serious sequelae. An association between these two conditions has been recognised but the nature of this relationship remains a topic of active debate. Despite that lack of strong, randomised controlled trials, there is a considerable body of data indicating that not only does untreated OSA provide the substrates and triggers for AF but that OSA, itself, is also a therapeutic target for the management of cardiovascular disease in general and of AF in particular.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Zaidon MBBCh, Jonathan MBBS, Bsc(Med), FRACP, PhD, Hany MBBS, PhD, FRACP,